LPL Financial
DRUG

LPL Financial’s Bright Minds Biosciences DRUG Stock Holding History

LPL Financial’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$484K Buy
6,895
+400
+6% +$31.4K ﹤0.01% 5054
2026
Q1 		$474K Buy
6,495
+850
+15% +$68.4K ﹤0.01% 4797
2025
Q4 		$441K Hold
5,645
– – ﹤0.01% 4835
2025
Q3 		$342K Buy
+5,645
New +$219K ﹤0.01% 4946

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

LPL Financial's DRUG Position: Q2 2026 in Review

LPL Financial increased its Bright Minds Biosciences (DRUG) stake by 6.2% in Q2 2026, buying an estimated $31.4K and bringing the position to 6,895 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #5054.

LPL Financial first reported a position in DRUG in Q3 2025 and has held it in 4 quarters since. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • LPL Financial held 6,895 shares of Bright Minds Biosciences worth $484K as of Q2 2026.
  • LPL Financial bought 400 Bright Minds Biosciences shares in Q2 2026, an estimated $31.4K.
  • Bright Minds Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5054 holding.
  • LPL Financial first reported a position in Bright Minds Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.